Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00777868
Recruitment Status : Completed
First Posted : October 22, 2008
Last Update Posted : June 22, 2012
Information provided by (Responsible Party):
Dow Pharmaceutical Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2009
Actual Study Completion Date : April 2009